COVID-19 Impact on Global Neutropenia Drugs, Market Insights and Forecast to 2026
- BMR3903661
- 111 Pages
- June 2020
- Healthcare
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Neutropenia Drugs industry.
Based on our recent survey, we have several different scenarios about the Neutropenia Drugs YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Neutropenia Drugs will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Neutropenia Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Neutropenia Drugs market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Neutropenia Drugs market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global Neutropenia Drugs market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Neutropenia Drugs market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Neutropenia Drugs market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Neutropenia Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Neutropenia Drugs market.
The following manufacturers are covered in this report:
Apotex Inc.
Biogenomics Limited
Cellerant Therapeutics, Inc.
Coherus BioSciences, Inc.
Dr. Reddy’s Laboratories Limited
Ligand Pharmaceuticals, Inc.
NAL Pharmaceuticals Ltd.
Prolong Pharmaceuticals, LLC
Richter Gedeon Nyrt.
Sandoz International GmbH
Neutropenia Drugs Breakdown Data by Type
Capsule
Injection
Neutropenia Drugs Breakdown Data by Application
Hospital
Clinic
1.1 Neutropenia Drugs Product Introduction
1.2 Market Segments
1.3 Key Neutropenia Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Neutropenia Drugs Market Size Growth Rate by Type
1.4.2 Capsule
1.4.3 Injection
1.5 Market by Application
1.5.1 Global Neutropenia Drugs Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.6 Coronavirus Disease 2019 (Covid-19): Neutropenia Drugs Industry Impact
1.6.1 How the Covid-19 is Affecting the Neutropenia Drugs Industry
1.6.1.1 Neutropenia Drugs Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Neutropenia Drugs Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Neutropenia Drugs Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Neutropenia Drugs Market Size Estimates and Forecasts
2.1.1 Global Neutropenia Drugs Revenue 2015-2026
2.1.2 Global Neutropenia Drugs Sales 2015-2026
2.2 Neutropenia Drugs Market Size by Region: 2020 Versus 2026
2.2.1 Global Neutropenia Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Neutropenia Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Neutropenia Drugs Competitor Landscape by Players
3.1 Neutropenia Drugs Sales by Manufacturers
3.1.1 Neutropenia Drugs Sales by Manufacturers (2015-2020)
3.1.2 Neutropenia Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Neutropenia Drugs Revenue by Manufacturers
3.2.1 Neutropenia Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Neutropenia Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Neutropenia Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Neutropenia Drugs Revenue in 2019
3.2.5 Global Neutropenia Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Neutropenia Drugs Price by Manufacturers
3.4 Neutropenia Drugs Manufacturing Base Distribution, Product Types
3.4.1 Neutropenia Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Neutropenia Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Neutropenia Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Neutropenia Drugs Market Size by Type (2015-2020)
4.1.1 Global Neutropenia Drugs Sales by Type (2015-2020)
4.1.2 Global Neutropenia Drugs Revenue by Type (2015-2020)
4.1.3 Neutropenia Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Neutropenia Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Neutropenia Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Neutropenia Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Neutropenia Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Neutropenia Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
5.1 Global Neutropenia Drugs Market Size by Application (2015-2020)
5.1.1 Global Neutropenia Drugs Sales by Application (2015-2020)
5.1.2 Global Neutropenia Drugs Revenue by Application (2015-2020)
5.1.3 Neutropenia Drugs Price by Application (2015-2020)
5.2 Neutropenia Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Neutropenia Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Neutropenia Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Neutropenia Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Neutropenia Drugs by Country
6.1.1 North America Neutropenia Drugs Sales by Country
6.1.2 North America Neutropenia Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Neutropenia Drugs Market Facts & Figures by Type
6.3 North America Neutropenia Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Neutropenia Drugs by Country
7.1.1 Europe Neutropenia Drugs Sales by Country
7.1.2 Europe Neutropenia Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Neutropenia Drugs Market Facts & Figures by Type
7.3 Europe Neutropenia Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Neutropenia Drugs by Region
8.1.1 Asia Pacific Neutropenia Drugs Sales by Region
8.1.2 Asia Pacific Neutropenia Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Neutropenia Drugs Market Facts & Figures by Type
8.3 Asia Pacific Neutropenia Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Neutropenia Drugs by Country
9.1.1 Latin America Neutropenia Drugs Sales by Country
9.1.2 Latin America Neutropenia Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Neutropenia Drugs Market Facts & Figures by Type
9.3 Central & South America Neutropenia Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Neutropenia Drugs by Country
10.1.1 Middle East and Africa Neutropenia Drugs Sales by Country
10.1.2 Middle East and Africa Neutropenia Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Neutropenia Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Neutropenia Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Apotex Inc.
11.1.1 Apotex Inc. Corporation Information
11.1.2 Apotex Inc. Description, Business Overview and Total Revenue
11.1.3 Apotex Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Apotex Inc. Neutropenia Drugs Products Offered
11.1.5 Apotex Inc. Recent Development
11.2 Biogenomics Limited
11.2.1 Biogenomics Limited Corporation Information
11.2.2 Biogenomics Limited Description, Business Overview and Total Revenue
11.2.3 Biogenomics Limited Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Biogenomics Limited Neutropenia Drugs Products Offered
11.2.5 Biogenomics Limited Recent Development
11.3 Cellerant Therapeutics, Inc.
11.3.1 Cellerant Therapeutics, Inc. Corporation Information
11.3.2 Cellerant Therapeutics, Inc. Description, Business Overview and Total Revenue
11.3.3 Cellerant Therapeutics, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Cellerant Therapeutics, Inc. Neutropenia Drugs Products Offered
11.3.5 Cellerant Therapeutics, Inc. Recent Development
11.4 Coherus BioSciences, Inc.
11.4.1 Coherus BioSciences, Inc. Corporation Information
11.4.2 Coherus BioSciences, Inc. Description, Business Overview and Total Revenue
11.4.3 Coherus BioSciences, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Coherus BioSciences, Inc. Neutropenia Drugs Products Offered
11.4.5 Coherus BioSciences, Inc. Recent Development
11.5 Dr. Reddy’s Laboratories Limited
11.5.1 Dr. Reddy’s Laboratories Limited Corporation Information
11.5.2 Dr. Reddy’s Laboratories Limited Description, Business Overview and Total Revenue
11.5.3 Dr. Reddy’s Laboratories Limited Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Dr. Reddy’s Laboratories Limited Neutropenia Drugs Products Offered
11.5.5 Dr. Reddy’s Laboratories Limited Recent Development
11.6 Ligand Pharmaceuticals, Inc.
11.6.1 Ligand Pharmaceuticals, Inc. Corporation Information
11.6.2 Ligand Pharmaceuticals, Inc. Description, Business Overview and Total Revenue
11.6.3 Ligand Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Ligand Pharmaceuticals, Inc. Neutropenia Drugs Products Offered
11.6.5 Ligand Pharmaceuticals, Inc. Recent Development
11.7 NAL Pharmaceuticals Ltd.
11.7.1 NAL Pharmaceuticals Ltd. Corporation Information
11.7.2 NAL Pharmaceuticals Ltd. Description, Business Overview and Total Revenue
11.7.3 NAL Pharmaceuticals Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.7.4 NAL Pharmaceuticals Ltd. Neutropenia Drugs Products Offered
11.7.5 NAL Pharmaceuticals Ltd. Recent Development
11.8 Prolong Pharmaceuticals, LLC
11.8.1 Prolong Pharmaceuticals, LLC Corporation Information
11.8.2 Prolong Pharmaceuticals, LLC Description, Business Overview and Total Revenue
11.8.3 Prolong Pharmaceuticals, LLC Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Prolong Pharmaceuticals, LLC Neutropenia Drugs Products Offered
11.8.5 Prolong Pharmaceuticals, LLC Recent Development
11.9 Richter Gedeon Nyrt.
11.9.1 Richter Gedeon Nyrt. Corporation Information
11.9.2 Richter Gedeon Nyrt. Description, Business Overview and Total Revenue
11.9.3 Richter Gedeon Nyrt. Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Richter Gedeon Nyrt. Neutropenia Drugs Products Offered
11.9.5 Richter Gedeon Nyrt. Recent Development
11.10 Sandoz International GmbH
11.10.1 Sandoz International GmbH Corporation Information
11.10.2 Sandoz International GmbH Description, Business Overview and Total Revenue
11.10.3 Sandoz International GmbH Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Sandoz International GmbH Neutropenia Drugs Products Offered
11.10.5 Sandoz International GmbH Recent Development
11.1 Apotex Inc.
11.1.1 Apotex Inc. Corporation Information
11.1.2 Apotex Inc. Description, Business Overview and Total Revenue
11.1.3 Apotex Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Apotex Inc. Neutropenia Drugs Products Offered
11.1.5 Apotex Inc. Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Neutropenia Drugs Market Estimates and Projections by Region
12.1.1 Global Neutropenia Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Neutropenia Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Neutropenia Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Neutropenia Drugs Sales Forecast (2021-2026)
12.2.2 North America: Neutropenia Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Neutropenia Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Neutropenia Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Neutropenia Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Neutropenia Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Neutropenia Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Neutropenia Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Neutropenia Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Neutropenia Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Neutropenia Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Neutropenia Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Neutropenia Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Neutropenia Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Neutropenia Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Neutropenia Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Neutropenia Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Neutropenia Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Neutropenia Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Neutropenia Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Neutropenia Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
Table 1. Neutropenia Drugs Market Segments
Table 2. Ranking of Global Top Neutropenia Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Neutropenia Drugs Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Capsule
Table 5. Major Manufacturers of Injection
Table 6. COVID-19 Impact Global Market: (Four Neutropenia Drugs Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Neutropenia Drugs Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Neutropenia Drugs Players to Combat Covid-19 Impact
Table 11. Global Neutropenia Drugs Market Size Growth Rate by Application 2020-2026 (K MT)
Table 12. Global Neutropenia Drugs Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 13. Global Neutropenia Drugs Sales by Regions 2015-2020 (K MT)
Table 14. Global Neutropenia Drugs Sales Market Share by Regions (2015-2020)
Table 15. Global Neutropenia Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Neutropenia Drugs Sales by Manufacturers (2015-2020) (K MT)
Table 17. Global Neutropenia Drugs Sales Share by Manufacturers (2015-2020)
Table 18. Global Neutropenia Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Neutropenia Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neutropenia Drugs as of 2019)
Table 20. Neutropenia Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Neutropenia Drugs Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Neutropenia Drugs Price (2015-2020) (USD/MT)
Table 23. Neutropenia Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Neutropenia Drugs Product Type
Table 25. Date of International Manufacturers Enter into Neutropenia Drugs Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Neutropenia Drugs Sales by Type (2015-2020) (K MT)
Table 28. Global Neutropenia Drugs Sales Share by Type (2015-2020)
Table 29. Global Neutropenia Drugs Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Neutropenia Drugs Revenue Share by Type (2015-2020)
Table 31. Neutropenia Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 32. Global Neutropenia Drugs Sales by Application (2015-2020) (K MT)
Table 33. Global Neutropenia Drugs Sales Share by Application (2015-2020)
Table 34. North America Neutropenia Drugs Sales by Country (2015-2020) (K MT)
Table 35. North America Neutropenia Drugs Sales Market Share by Country (2015-2020)
Table 36. North America Neutropenia Drugs Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Neutropenia Drugs Revenue Market Share by Country (2015-2020)
Table 38. North America Neutropenia Drugs Sales by Type (2015-2020) (K MT)
Table 39. North America Neutropenia Drugs Sales Market Share by Type (2015-2020)
Table 40. North America Neutropenia Drugs Sales by Application (2015-2020) (K MT)
Table 41. North America Neutropenia Drugs Sales Market Share by Application (2015-2020)
Table 42. Europe Neutropenia Drugs Sales by Country (2015-2020) (K MT)
Table 43. Europe Neutropenia Drugs Sales Market Share by Country (2015-2020)
Table 44. Europe Neutropenia Drugs Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Neutropenia Drugs Revenue Market Share by Country (2015-2020)
Table 46. Europe Neutropenia Drugs Sales by Type (2015-2020) (K MT)
Table 47. Europe Neutropenia Drugs Sales Market Share by Type (2015-2020)
Table 48. Europe Neutropenia Drugs Sales by Application (2015-2020) (K MT)
Table 49. Europe Neutropenia Drugs Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Neutropenia Drugs Sales by Region (2015-2020) (K MT)
Table 51. Asia Pacific Neutropenia Drugs Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Neutropenia Drugs Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Neutropenia Drugs Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Neutropenia Drugs Sales by Type (2015-2020) (K MT)
Table 55. Asia Pacific Neutropenia Drugs Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Neutropenia Drugs Sales by Application (2015-2020) (K MT)
Table 57. Asia Pacific Neutropenia Drugs Sales Market Share by Application (2015-2020)
Table 58. Latin America Neutropenia Drugs Sales by Country (2015-2020) (K MT)
Table 59. Latin America Neutropenia Drugs Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Neutropenia Drugs Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Neutropenia Drugs Revenue Market Share by Country (2015-2020)
Table 62. Latin America Neutropenia Drugs Sales by Type (2015-2020) (K MT)
Table 63. Latin America Neutropenia Drugs Sales Market Share by Type (2015-2020)
Table 64. Latin America Neutropenia Drugs Sales by Application (2015-2020) (K MT)
Table 65. Latin America Neutropenia Drugs Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Neutropenia Drugs Sales by Country (2015-2020) (K MT)
Table 67. Middle East and Africa Neutropenia Drugs Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Neutropenia Drugs Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Neutropenia Drugs Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Neutropenia Drugs Sales by Type (2015-2020) (K MT)
Table 71. Middle East and Africa Neutropenia Drugs Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Neutropenia Drugs Sales by Application (2015-2020) (K MT)
Table 73. Middle East and Africa Neutropenia Drugs Sales Market Share by Application (2015-2020)
Table 74. Apotex Inc. Corporation Information
Table 75. Apotex Inc. Description and Major Businesses
Table 76. Apotex Inc. Neutropenia Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Apotex Inc. Product
Table 78. Apotex Inc. Recent Development
Table 79. Biogenomics Limited Corporation Information
Table 80. Biogenomics Limited Description and Major Businesses
Table 81. Biogenomics Limited Neutropenia Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Biogenomics Limited Product
Table 83. Biogenomics Limited Recent Development
Table 84. Cellerant Therapeutics, Inc. Corporation Information
Table 85. Cellerant Therapeutics, Inc. Description and Major Businesses
Table 86. Cellerant Therapeutics, Inc. Neutropenia Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Cellerant Therapeutics, Inc. Product
Table 88. Cellerant Therapeutics, Inc. Recent Development
Table 89. Coherus BioSciences, Inc. Corporation Information
Table 90. Coherus BioSciences, Inc. Description and Major Businesses
Table 91. Coherus BioSciences, Inc. Neutropenia Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Coherus BioSciences, Inc. Product
Table 93. Coherus BioSciences, Inc. Recent Development
Table 94. Dr. Reddy’s Laboratories Limited Corporation Information
Table 95. Dr. Reddy’s Laboratories Limited Description and Major Businesses
Table 96. Dr. Reddy’s Laboratories Limited Neutropenia Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Dr. Reddy’s Laboratories Limited Product
Table 98. Dr. Reddy’s Laboratories Limited Recent Development
Table 99. Ligand Pharmaceuticals, Inc. Corporation Information
Table 100. Ligand Pharmaceuticals, Inc. Description and Major Businesses
Table 101. Ligand Pharmaceuticals, Inc. Neutropenia Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. Ligand Pharmaceuticals, Inc. Product
Table 103. Ligand Pharmaceuticals, Inc. Recent Development
Table 104. NAL Pharmaceuticals Ltd. Corporation Information
Table 105. NAL Pharmaceuticals Ltd. Description and Major Businesses
Table 106. NAL Pharmaceuticals Ltd. Neutropenia Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. NAL Pharmaceuticals Ltd. Product
Table 108. NAL Pharmaceuticals Ltd. Recent Development
Table 109. Prolong Pharmaceuticals, LLC Corporation Information
Table 110. Prolong Pharmaceuticals, LLC Description and Major Businesses
Table 111. Prolong Pharmaceuticals, LLC Neutropenia Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Prolong Pharmaceuticals, LLC Product
Table 113. Prolong Pharmaceuticals, LLC Recent Development
Table 114. Richter Gedeon Nyrt. Corporation Information
Table 115. Richter Gedeon Nyrt. Description and Major Businesses
Table 116. Richter Gedeon Nyrt. Neutropenia Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Richter Gedeon Nyrt. Product
Table 118. Richter Gedeon Nyrt. Recent Development
Table 119. Sandoz International GmbH Corporation Information
Table 120. Sandoz International GmbH Description and Major Businesses
Table 121. Sandoz International GmbH Neutropenia Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 122. Sandoz International GmbH Product
Table 123. Sandoz International GmbH Recent Development
Table 124. Global Neutropenia Drugs Sales Forecast by Regions (2021-2026) (K MT)
Table 125. Global Neutropenia Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 126. Global Neutropenia Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 127. Global Neutropenia Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 128. North America: Neutropenia Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 129. North America: Neutropenia Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 130. Europe: Neutropenia Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 131. Europe: Neutropenia Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 132. Asia Pacific: Neutropenia Drugs Sales Forecast by Region (2021-2026) (K MT)
Table 133. Asia Pacific: Neutropenia Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 134. Latin America: Neutropenia Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 135. Latin America: Neutropenia Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 136. Middle East and Africa: Neutropenia Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 137. Middle East and Africa: Neutropenia Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 138. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 139. Key Challenges
Table 140. Market Risks
Table 141. Main Points Interviewed from Key Neutropenia Drugs Players
Table 142. Neutropenia Drugs Customers List
Table 143. Neutropenia Drugs Distributors List
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Neutropenia Drugs Product Picture
Figure 2. Global Neutropenia Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Capsule Product Picture
Figure 4. Injection Product Picture
Figure 5. Global Neutropenia Drugs Sales Market Share by Application in 2020 & 2026
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Neutropenia Drugs Report Years Considered
Figure 9. Global Neutropenia Drugs Market Size 2015-2026 (US$ Million)
Figure 10. Global Neutropenia Drugs Sales 2015-2026 (K MT)
Figure 11. Global Neutropenia Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Neutropenia Drugs Sales Market Share by Region (2015-2020)
Figure 13. Global Neutropenia Drugs Sales Market Share by Region in 2019
Figure 14. Global Neutropenia Drugs Revenue Market Share by Region (2015-2020)
Figure 15. Global Neutropenia Drugs Revenue Market Share by Region in 2019
Figure 16. Global Neutropenia Drugs Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Neutropenia Drugs Revenue in 2019
Figure 18. Neutropenia Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Neutropenia Drugs Sales Market Share by Type (2015-2020)
Figure 20. Global Neutropenia Drugs Sales Market Share by Type in 2019
Figure 21. Global Neutropenia Drugs Revenue Market Share by Type (2015-2020)
Figure 22. Global Neutropenia Drugs Revenue Market Share by Type in 2019
Figure 23. Global Neutropenia Drugs Market Share by Price Range (2015-2020)
Figure 24. Global Neutropenia Drugs Sales Market Share by Application (2015-2020)
Figure 25. Global Neutropenia Drugs Sales Market Share by Application in 2019
Figure 26. Global Neutropenia Drugs Revenue Market Share by Application (2015-2020)
Figure 27. Global Neutropenia Drugs Revenue Market Share by Application in 2019
Figure 28. North America Neutropenia Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 29. North America Neutropenia Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 30. North America Neutropenia Drugs Sales Market Share by Country in 2019
Figure 31. North America Neutropenia Drugs Revenue Market Share by Country in 2019
Figure 32. U.S. Neutropenia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 33. U.S. Neutropenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Canada Neutropenia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 35. Canada Neutropenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. North America Neutropenia Drugs Market Share by Type in 2019
Figure 37. North America Neutropenia Drugs Market Share by Application in 2019
Figure 38. Europe Neutropenia Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 39. Europe Neutropenia Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. Europe Neutropenia Drugs Sales Market Share by Country in 2019
Figure 41. Europe Neutropenia Drugs Revenue Market Share by Country in 2019
Figure 42. Germany Neutropenia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 43. Germany Neutropenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. France Neutropenia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 45. France Neutropenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. U.K. Neutropenia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 47. U.K. Neutropenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Italy Neutropenia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 49. Italy Neutropenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Russia Neutropenia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 51. Russia Neutropenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe Neutropenia Drugs Market Share by Type in 2019
Figure 53. Europe Neutropenia Drugs Market Share by Application in 2019
Figure 54. Asia Pacific Neutropenia Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 55. Asia Pacific Neutropenia Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 56. Asia Pacific Neutropenia Drugs Sales Market Share by Region in 2019
Figure 57. Asia Pacific Neutropenia Drugs Revenue Market Share by Region in 2019
Figure 58. China Neutropenia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 59. China Neutropenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Japan Neutropenia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 61. Japan Neutropenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. South Korea Neutropenia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 63. South Korea Neutropenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. India Neutropenia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 65. India Neutropenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Australia Neutropenia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 67. Australia Neutropenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Taiwan Neutropenia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 69. Taiwan Neutropenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Indonesia Neutropenia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 71. Indonesia Neutropenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Thailand Neutropenia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 73. Thailand Neutropenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Malaysia Neutropenia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 75. Malaysia Neutropenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Philippines Neutropenia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 77. Philippines Neutropenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Vietnam Neutropenia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 79. Vietnam Neutropenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Asia Pacific Neutropenia Drugs Market Share by Type in 2019
Figure 81. Asia Pacific Neutropenia Drugs Market Share by Application in 2019
Figure 82. Latin America Neutropenia Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 83. Latin America Neutropenia Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 84. Latin America Neutropenia Drugs Sales Market Share by Country in 2019
Figure 85. Latin America Neutropenia Drugs Revenue Market Share by Country in 2019
Figure 86. Mexico Neutropenia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 87. Mexico Neutropenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Brazil Neutropenia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 89. Brazil Neutropenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Argentina Neutropenia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 91. Argentina Neutropenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Latin America Neutropenia Drugs Market Share by Type in 2019
Figure 93. Latin America Neutropenia Drugs Market Share by Application in 2019
Figure 94. Middle East and Africa Neutropenia Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 95. Middle East and Africa Neutropenia Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa Neutropenia Drugs Sales Market Share by Country in 2019
Figure 97. Middle East and Africa Neutropenia Drugs Revenue Market Share by Country in 2019
Figure 98. Turkey Neutropenia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 99. Turkey Neutropenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia Neutropenia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 101. Saudi Arabia Neutropenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. U.A.E Neutropenia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 103. U.A.E Neutropenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Middle East and Africa Neutropenia Drugs Market Share by Type in 2019
Figure 105. Middle East and Africa Neutropenia Drugs Market Share by Application in 2019
Figure 106. Apotex Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 107. Biogenomics Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. Cellerant Therapeutics, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Coherus BioSciences, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Dr. Reddy’s Laboratories Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Ligand Pharmaceuticals, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. NAL Pharmaceuticals Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Prolong Pharmaceuticals, LLC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Richter Gedeon Nyrt. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Sandoz International GmbH Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. North America Neutropenia Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 117. North America Neutropenia Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Europe Neutropenia Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 119. Europe Neutropenia Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Asia Pacific Neutropenia Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 121. Asia Pacific Neutropenia Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Latin America Neutropenia Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 123. Latin America Neutropenia Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Middle East and Africa Neutropenia Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 125. Middle East and Africa Neutropenia Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 126. Porter's Five Forces Analysis
Figure 127. Channels of Distribution
Figure 128. Distributors Profiles
Figure 129. Bottom-up and Top-down Approaches for This Report
Figure 130. Data Triangulation
Figure 131. Key Executives Interviewed
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
